News
Gilead's Q2 earnings beat and raised 2025 outlook lift shares 7.3%, fueled by HIV gains, Trodelvy strength, and new PrEP ...
What is MFN in pharma? President Trump’s executive order on drug pricing states that the United States should be treated as a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback